Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Precursor natural killer cell leukemia.

Xiayuan Liang1, Brian Greffe, Timothy Garrington

  • 1Department of Pathology, University of Colorado School of Medicine, Denver, USA. liang.xiayuan@tchden.orgc

Pediatric Blood & Cancer
|April 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrent SWI/SNF Deficiency Defines a Subset of Peripheral T-Cell Lymphoma With Distinct Clinicopathologic Features.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Free-floating long-term vascularized mesenchymal organoids.

iScience·2026
Same author

iMer, a naturally occurring MERTK splice variant, binds to GAS6 to decrease platelet activation and thrombus formation.

Blood vessels, thrombosis & hemostasis·2025
Same author

Anti-Tumor Activity of Paclitaxel-Containing Regimens in Recurrent/Refractory Wilms Tumor.

Pediatric blood & cancer·2025
Same author

Prospects of current AXL-targeting therapies in early phase cancer trials.

Expert opinion on investigational drugs·2025
Same author

Sinonasal Teratocarcinosarcoma: A Case Report in a 13-Year-Old Male.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2025
Same journal

Comment on: "The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience"-The Evolving Role of the BIT Regimen.

Pediatric blood & cancer·2026
Same journal

Extramedullary Intradural Spinal Tumor in an Infant With Neurocutaneous Melanosis.

Pediatric blood & cancer·2026
Same journal

The Role of Hematopoietic Cell Transplantation in Ataxia-Telangiectasia.

Pediatric blood & cancer·2026
Same journal

Pediatric T-Lymphoblastic Lymphoma With T(9;17) and MIR142HG::NOTCH1 Fusion Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation in First Complete Remission.

Pediatric blood & cancer·2026
Same journal

Reply to: Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Pediatric blood & cancer·2026
Same journal

Comment on: Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Pediatric blood & cancer·2026
See all related articles

This study details a rare pediatric precursor Natural Killer (NK) cell leukemia case. It reviews existing literature to improve understanding of immature NK cell tumor diagnosis, treatment, and outcomes in children.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Immunology

Background:

  • Natural killer (NK) cell tumors are rare and diverse hematologic malignancies.
  • Immature NK cell tumors are less understood than mature subtypes, particularly in pediatric populations.
  • Limited diagnostic and treatment experience exists for immature NK cell tumors in children.

Observation:

  • A pediatric case of precursor NK cell leukemia is presented.
  • A comprehensive literature review of previously reported pediatric cases was conducted.

Findings:

  • The case and literature review aim to better characterize precursor NK cell leukemia in children.
  • This analysis seeks to define diagnostic criteria and optimal therapeutic strategies.
  • Understanding treatment outcomes for pediatric immature NK cell tumors is a key objective.

Related Experiment Videos

Implications:

  • Improved characterization can lead to earlier diagnosis and more effective treatment protocols for pediatric NK cell tumors.
  • This research contributes to the limited knowledge base for rare pediatric hematologic malignancies.
  • Enhanced understanding may guide future clinical trials and therapeutic development for immature NK cell neoplasms.